EVC Group Alternative
EVC Group for life sciences. AxonIR for life sciences + AI.
AxonIR is the AI-native investor relations firm for NYSE and NASDAQ micro/small-cap companies. Save $42,000 – $108,000/year vs EVC Group while gaining 12 AI capabilities they cannot match at any price.
EVC Group vs AxonIR — Side by Side
Legacy
EVC Group
Monthly$5,000–$10,000/month
FocusLife sciences & tech small-caps
AI Capabilities✗ None
ContractAnnual commitment
- EVC Group retainer $5K–$10K/mo
- Sector expertise but no AI/NLP technology
- Limited algo signal monitoring
- No short-seller early warning
- No activist threat prediction
Recommended
AI-Native
AxonIR
Monthly$750–$4,000
FocusNYSE/NASDAQ <$500M + AI
AI Capabilities✓ 12 native
ContractMonth-to-month
- Sector expertise + AI platform. AxonIR handles life sciences, tech, SaaS, industrials with equally sophisticated NLP scoring — plus a dedicated analyst at Scale/Enterprise tier.
- 50-80% savings. $1,500–$4,000 vs $7,500/mo average.
- Biotech short-seller defense. Biotechs face the most short-seller attacks. AxonIR's early warning system is critical for sector-specific defense.
You Save $42,000 – $108,000/year
Replacing EVC Group with AxonIR cuts your IR spend 50-90% while adding AI capabilities that make you visible to the 70% of trading that is algorithmic.
See Your Free Algo ScoreWhy Companies Switch from EVC Group to AxonIR
01
Sector expertise + AI platform
AxonIR handles life sciences, tech, SaaS, industrials with equally sophisticated NLP scoring — plus a dedicated analyst at Scale/Enterprise tier.
02
50-80% savings
$1,500–$4,000 vs $7,500/mo average.
03
Biotech short-seller defense
Biotechs face the most short-seller attacks. AxonIR's early warning system is critical for sector-specific defense.
Ready to leave EVC Group?
Start with a free algo score. No credit card required.